VANTAS Side Effects

6859297-0 | Device Expulsion, Device Extrusion, Implant Site Discharge, Infection
on Jul 12, 2010 Male patient from UNITED STATES , 79 years of age, weighting 160.0 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Vantas (View Usage). Patient experienced the following unwanted or unexpected effects: device expulsion, device extrusion, implant site discharge, infection (What is infection?). Vantas dosage: 1 In 1 Y, Sub Q. Implant.

6733021-4 | Lung Neoplasm Malignant, Malignant Neoplasm Progression
Patient was taking Vantas (View Usage). Patient had the following side effects: lung neoplasm malignant, malignant neoplasm progression on Apr 29, 2010 from FINLAND Additional patient health information: Male patient , 78 years of age, weighting 99.21 lb, was diagnosed with prostate cancer (What is prostate cancer?) and. Vantas dosage: 1 In 1 Y, Sub Q. Implant.

6719700-3 | Lung Neoplasm Malignant
Adverse event was reported on Apr 22, 2010 by a Male patient taking Vantas (View Usage) (Dosage: 1 In 1 Y, Sub Q. Implant) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: FINLAND , 78 years of age, After Vantas was administered, patient had the following side effects: lung neoplasm malignant.

6526807-2 | Cholestasis, Hepatic Necrosis, Hepatocellular Injury, Hepatotoxicity
on Dec 16, 2009 Male patient from UNITED STATES , 69 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Vantas (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, hepatic necrosis, hepatocellular injury, hepatotoxicity. Vantas dosage: 1 In 1 Y, Sub Q.implant. During the same period patient was treated with KETOCONAZOLE (View Ketoconazole Review and Ketoconazole Label ), HYDROCORTONE (View Hydrocortone Review and Hydrocortone Label ), TENORMIN (View Tenormin Review and Tenormin Label ), ADALAT (View Adalat Review and Adalat Label ), NEXIUM (View Nexium Review and Nexium Label ), MICROZIDE (View Microzide Review and Microzide Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).


6512665-9 | Contraindication To Medical Treatment
on Dec 02, 2009 Male patient from UNITED STATES , child 10 years of age, was diagnosed with precocious puberty and was treated with Vantas (View Usage). Patient had the following side effects: contraindication to medical treatment. Vantas dosage: 1 In 1 Y, Sub Q. Implant. During the same period patient was treated with LUPRON (View Lupron Review and Lupron Label ).

6369370-1 | Ankle Fracture, Bone Pain, Fall, Lower Limb Fracture, Osteoporosis
Patient was taking Vantas (View Usage). After Vantas was administered, patient had the following side effects: ankle fracture, bone pain, fall (What is fall?), lower limb fracture, osteoporosis (What is osteoporosis?) on Sep 08, 2009 from UNITED STATES Additional patient health information: Male patient , 69 years of age, weighting 278.0 lb, was diagnosed with prostatic specific antigen abnormal and. Vantas dosage: 1 In 1 Y, Sub Q. Implant. During the same period patient was treated with PRIOLOSEC (OMEPRAZOLE) (View Priolosec (omeprazole) Review and Priolosec (omeprazole) Label ), NEXIUM (View Nexium Review and Nexium Label ), ULTRACET (ULTRACET) (View Ultracet (ultracet) Review and Ultracet (ultracet) Label ). Patient was hospitalized.

6348368-3 | Fall, Gait Disturbance
Adverse event was reported on Sep 01, 2009 by a Male patient taking Vantas (View Usage) (Dosage: 1 In 1 Y, Sub Q. Implant) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , 70 years of age, weighting 224.0 lb, Patient experienced the following unwanted or unexpected effects: fall (What is fall?), gait disturbance. During the same period patient was treated with DILANTIN (PHENYTOIN) (100 MILLIGRAM) (View Dilantin (phenytoin) (100 Milligram) Review and Dilantin (phenytoin) (100 Milligram) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AVAPRO (IRBESARTAN) (150 MILLIGRAM) (View Avapro (irbesartan) (150 Milligram) Review and Avapro (irbesartan) (150 Milligram) Label ), PLAVIX (View Plavix Review and Plavix Label ), ADVIL (View Advil Review and Advil Label ).

6338373-5 | Basal Ganglia Haemorrhage
on Aug 21, 2009 Male patient from UNITED STATES , 86 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Vantas (View Usage). Patient had the following side effects: basal ganglia haemorrhage. Vantas dosage: 1 In 1 Y, Sub Q. Implant. During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), HERBACET (HERBAL PREPARATION) (View Herbacet (herbal Preparation) Review and Herbacet (herbal Preparation) Label ). Patient was hospitalized.

6033260-4 | Dyspnoea, Oedema, Rash Pruritic
on Dec 22, 2008 Male patient from UNITED STATES , 73 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Vantas (View Usage). After Vantas was administered, patient had the following side effects: dyspnoea, oedema, rash pruritic. Vantas dosage: 50 Mg, 1 In 1 Y, Sub Q. Implant. Patient was hospitalized.

5884183-2 | Implant Site Cellulitis
Patient was taking Vantas (View Usage). Patient experienced the following unwanted or unexpected effects: implant site cellulitis on Aug 27, 2008 from UNITED STATES Additional patient health information: Male patient , 78 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Vantas dosage: 50 Mg, 1 In 1 Y, Sub Q. Implant. During the same period patient was treated with SANCTURA XR (TROSPIUM CHLORIDE) (View Sanctura Xr (trospium Chloride) Review and Sanctura Xr (trospium Chloride) Label ). Patient was hospitalized.

5844456-6 | Cellulitis
Adverse event was reported on Jul 28, 2008 by a Male patient taking Vantas (View Usage) (Dosage: 50 Mg, 1 In 1y, Sub Q. Implant) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , 78 years of age, Patient had the following side effects: cellulitis (What is cellulitis?). During the same period patient was treated with SANCTURA XR (TROSPIUM CHLORIDE) (View Sanctura Xr (trospium Chloride) Review and Sanctura Xr (trospium Chloride) Label ). Patient was hospitalized.

5813955-5 | Blood Creatinine Increased, Dialysis
on Jul 09, 2008 Male patient from UNITED STATES , 83 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Vantas (View Usage). After Vantas was administered, patient had the following side effects: blood creatinine increased, dialysis (What is dialysis?). Vantas dosage: 50 Mg, 1 In 1 Y, Sub Q, Implant. During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NEPHROVITE (NEPHROVITE) (View Nephrovite (nephrovite) Review and Nephrovite (nephrovite) Label ). Patient was hospitalized.

5506564-9 | Shock, Vomiting
on Oct 25, 2007 Male patient from UNITED STATES , 95 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Vantas (View Usage). Patient experienced the following unwanted or unexpected effects: shock, vomiting. Vantas dosage: 50 Mg, 1 In 1 Y, Sub Q. Implant. During the same period patient was treated with HYZAAR (View Hyzaar Review and Hyzaar Label ), KCL SUPPLEMENT (POTASSIUM CHLORIDE) (View Kcl Supplement (potassium Chloride) Review and Kcl Supplement (potassium Chloride) Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

5492055-0 | Shock, Vomiting
Patient was taking Vantas (View Usage). Patient had the following side effects: shock, vomiting on Oct 05, 2007 from UNITED STATES Additional patient health information: Male patient , 90 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Vantas dosage: 50 Mg, 1 In 1 Y, Sub Q. Implant.

5308283-0 | Cerebrovascular Accident, Hypoaesthesia, Oedema Peripheral
Adverse event was reported on Apr 17, 2007 by a Male patient taking Vantas (View Usage) (Dosage: 50 Mg, 1 In 1 Y, Sub Q. Implant) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , 88 years of age, weighting 192.0 lb, After Vantas was administered, patient had the following side effects: cerebrovascular accident, hypoaesthesia, oedema peripheral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), DIOVAN HCT (CO DIOVAN) (View Diovan Hct (co-diovan) Review and Diovan Hct (co-diovan) Label ), CRESTOR (ROSUVASTATIN) (5 MILLIGRAM) (View Crestor (rosuvastatin) (5 Milligram) Review and Crestor (rosuvastatin) (5 Milligram) Label ), METFORMIN (METFORMIN) (500 MILLIGRAM) (View Metformin (metformin) (500 Milligram) Review and Metformin (metformin) (500 Milligram) Label ), CASODEX (BICALUTAMIDE) (50 MILLIGRAM) (View Casodex (bicalutamide) (50 Milligram) Review and Casodex (bicalutamide) (50 Milligram) Label ).

5292675-2 | Carotid Artery Occlusion, Cerebrovascular Accident, Oedema Peripheral
on Mar 28, 2007 Male patient from UNITED STATES , 88 years of age, weighting 192.0 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Vantas (View Usage). Patient experienced the following unwanted or unexpected effects: carotid artery occlusion, cerebrovascular accident, oedema peripheral. Vantas dosage: 50 Mg, 1 In 1 Y, Sub Q. Implant. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), DIOVAN HCT (CO DIOVAN) (View Diovan Hct (co-diovan) Review and Diovan Hct (co-diovan) Label ), CRESTOR (View Crestor Review and Crestor Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), CASODEX (View Casodex Review and Casodex Label ).

5290169-1 | Carotid Artery Occlusion, Cerebrovascular Accident, Hypoaesthesia, Oedema Peripheral
on Mar 27, 2007 Male patient from UNITED STATES , 88 years of age, weighting 192.0 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Vantas (View Usage). Patient had the following side effects: carotid artery occlusion, cerebrovascular accident, hypoaesthesia, oedema peripheral. Vantas dosage: 50 Mg, 1 In 1 Y, Sub Q. Implant. During the same period patient was treated with ECOTRIN (ACETYLSALICYLIC ACID) (325 MILLIGRAM) (View Ecotrin (acetylsalicylic Acid) (325 Milligram) Review and Ecotrin (acetylsalicylic Acid) (325 Milligram) Label ), DIOVAN HCT (CO DIOVAN) (View Diovan Hct (co-diovan) Review and Diovan Hct (co-diovan) Label ), CRESTOR (ROSUVASTATIN) (5 MILLIGRAM) (View Crestor (rosuvastatin) (5 Milligram) Review and Crestor (rosuvastatin) (5 Milligram) Label ), METFORMIN (METFORMIN) (500 MILLIGRAM) (View Metformin (metformin) (500 Milligram) Review and Metformin (metformin) (500 Milligram) Label ), CASODEX (BICALUTAMIDE) (50 MILLIGRAM) (View Casodex (bicalutamide) (50 Milligram) Review and Casodex (bicalutamide) (50 Milligram) Label ). Patient was hospitalized.

5274703-3 | Cerebrovascular Accident, Hypoaesthesia, Oedema Peripheral
Patient was taking Vantas (View Usage). After Vantas was administered, patient had the following side effects: cerebrovascular accident, hypoaesthesia, oedema peripheral on Mar 09, 2007 from UNITED STATES Additional patient health information: Male patient , 88 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Vantas dosage: 50 Mg, 1 In 1 Y, Sub Q. Implant. Patient was hospitalized.

4968958-X | Bone Pain, Convulsion, Depression, Epistaxis, Hot Flush, Hyperhidrosis, Insomnia, Muscle Twitching, Pollakiuria
Adverse event was reported on Mar 30, 2006 by a Male patient taking Vantas (View Usage) (Dosage: 50 Mg/year, Subcutaneous) was diagnosed with prostate cancer metastatic and. Location: UNITED STATES , 68 years of age, Patient experienced the following unwanted or unexpected effects: bone pain, convulsion, depression (What is depression?), epistaxis, hot flush, hyperhidrosis, insomnia, muscle twitching, pollakiuria. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ), HYDROMORPHINE (View Hydromorphine Review and Hydromorphine Label ).

4945414-6 | Device Migration, Failure Of Implant
on Mar 07, 2006 Male patient from UNITED STATES , 81 years of age, weighting 185.0 lb, was diagnosed with disease recurrence, prostate cancer (What is prostate cancer?) and was treated with Vantas (View Usage). Patient had the following side effects: device migration, failure of implant. Vantas dosage: 1 Year Period Insert 1 Time Arm.

4834884-X | Blood Testosterone Increased, Implant Site Reaction, Prostatic Specific Antigen Increased
on Nov 04, 2005 Male patient from UNITED STATES , 69 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Vantas (View Usage). After Vantas was administered, patient had the following side effects: blood testosterone increased, implant site reaction, prostatic specific antigen increased. Vantas dosage: 50mg/year, Subcutaneous.

4748629-5 | Angioplasty, Blood Creatine Phosphokinase Increased, C-reactive Protein Increased, Hypoxia, Polymyositis, Red Blood Cell Sedimentation Rate Increased, Vital Capacity Decreased
Patient was taking Vantas (View Usage). Patient experienced the following unwanted or unexpected effects: angioplasty (What is angioplasty?), blood creatine phosphokinase increased, c-reactive protein increased, hypoxia, polymyositis, red blood cell sedimentation rate increased, vital capacity decreased on May 27, 2005 from UNITED STATES Additional patient health information: Male patient , 68 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Vantas dosage: 50mg/year, Subcutaneous. During the same period patient was treated with CLOPIDPGREL BISULFATE (PLAVIX) (View Clopidpgrel Bisulfate (plavix) Review and Clopidpgrel Bisulfate (plavix) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ENOXAPARIN SODIUM (LOVENOX) (View Enoxaparin Sodium (lovenox) Review and Enoxaparin Sodium (lovenox) Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), PROZAC (View Prozac Review and Prozac Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ). Patient was hospitalized.

4616461-9 | Dysuria, Oesophageal Varices Haemorrhage, Prostatic Specific Antigen Increased, Refusal Of Treatment By Patient
Adverse event was reported on Dec 01, 2004 by a Male patient taking Vantas (View Usage) (Dosage: 50mg/year, Subcutaneous) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: , 78 years of age, weighting 160.0 lb, Patient had the following side effects: dysuria, oesophageal varices haemorrhage, prostatic specific antigen increased, refusal of treatment by patient. During the same period patient was treated with GLUCOTROL (View Glucotrol Review and Glucotrol Label ), METFORMIN HCL (GLUCOPHAGE) (View Metformin Hcl (glucophage) Review and Metformin Hcl (glucophage) Label ), BICALUTAMIDE (CASODEX) (View Bicalutamide (casodex) Review and Bicalutamide (casodex) Label ).

4616460-7 | Cardiomyopathy, Refusal Of Treatment By Patient
on Dec 01, 2004 Male patient from , 85 years of age, weighting 145.0 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Vantas (View Usage). After Vantas was administered, patient had the following side effects: cardiomyopathy (What is cardiomyopathy?), refusal of treatment by patient. Vantas dosage: 50mg/year, Subcutaneous. During the same period patient was treated with AMLODIPINE BESYLATE (NORVASC) (View Amlodipine Besylate (norvasc) Review and Amlodipine Besylate (norvasc) Label ), METOPROLOL SUCCINATE (TOPROL) (View Metoprolol Succinate (toprol) Review and Metoprolol Succinate (toprol) Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), LASIX (View Lasix Review and Lasix Label ), ISOSORBIDE (View Isosorbide Review and Isosorbide Label ), NITROGLYN 2% OINTMENT (View Nitroglyn 2% Ointment Review and Nitroglyn 2% Ointment Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

4614263-0 | Chest Pain, Delirium, Fall, Implant Site Pain
on Mar 14, 2005 Male patient from , 84 years of age, weighting 150.0 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Vantas (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), delirium, fall (What is fall?), implant site pain. Vantas dosage: 50mg, 1/year, 057implant. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ZANTAC (View Zantac Review and Zantac Label ), CLINDEX (View Clindex Review and Clindex Label ), MEGACE (View Megace Review and Megace Label ), LIBRAX (View Librax Review and Librax Label ), PERPHENOZINE (View Perphenozine Review and Perphenozine Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), CELEXA (View Celexa Review and Celexa Label ).

4604294-9 |
Patient was taking Vantas (View Usage). on Dec 01, 2004 from Additional patient health information: Male patient , 85 years of age, weighting 145.0 lb, was diagnosed with prostate cancer (What is prostate cancer?) and. Vantas dosage: 50 Mg, Once Per Year, Implant 057. During the same period patient was treated with NORVASC 5 MG BID (View Norvasc 5 Mg Bid Review and Norvasc 5 Mg Bid Label ), TOPROL 25 MG BID (View Toprol 25 Mg Bid Review and Toprol 25 Mg Bid Label ), GLYBURIDE 5 MG BID (View Glyburide 5 Mg Bid Review and Glyburide 5 Mg Bid Label ), ENALAPRIL 5 MG (View Enalapril 5 Mg Review and Enalapril 5 Mg Label ), FUROSEMIDE 80 MG ONCE PER DAY (View Furosemide 80 Mg Once Per Day Review and Furosemide 80 Mg Once Per Day Label ), ISOSORBIDE ONCE PER DAY (View Isosorbide Once Per Day Review and Isosorbide Once Per Day Label ), NITRO PATCH ONCE PER DAY (View Nitro Patch Once Per Day Review and Nitro Patch Once Per Day Label ), ASPIRIN 81 MG ONCE PER DAY (View Aspirin 81 Mg Once Per Day Review and Aspirin 81 Mg Once Per Day Label ).

4604294-9 |
Adverse event was reported on Dec 01, 2004 by a Male patient taking Vantas (View Usage) (Dosage: 50 Mg, Once Per Year, Implant 057) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: , 85 years of age, weighting 145.0 lb, . During the same period patient was treated with NORVASC 5 MG BID (View Norvasc 5 Mg Bid Review and Norvasc 5 Mg Bid Label ), TOPROL 25 MG BID (View Toprol 25 Mg Bid Review and Toprol 25 Mg Bid Label ), GLYBURIDE 5 MG BID (View Glyburide 5 Mg Bid Review and Glyburide 5 Mg Bid Label ), ENALAPRIL 5 MG (View Enalapril 5 Mg Review and Enalapril 5 Mg Label ), FUROSEMIDE 80 MG ONCE PER DAY (View Furosemide 80 Mg Once Per Day Review and Furosemide 80 Mg Once Per Day Label ), ISOSORBIDE ONCE PER DAY (View Isosorbide Once Per Day Review and Isosorbide Once Per Day Label ), NITRO PATCH ONCE PER DAY (View Nitro Patch Once Per Day Review and Nitro Patch Once Per Day Label ), ASPIRIN 81 MG ONCE PER DAY (View Aspirin 81 Mg Once Per Day Review and Aspirin 81 Mg Once Per Day Label ).

4604291-3 |
on Dec 01, 2004 Male patient from , 78 years of age, weighting 160.0 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Vantas (View Usage). . Vantas dosage: 50 Mg, Once Per Year, Implant 057. During the same period patient was treated with GLUCOTROL (View Glucotrol Review and Glucotrol Label ), GLUCOPHAGE 500 MG TID (View Glucophage 500 Mg Tid Review and Glucophage 500 Mg Tid Label ), CASEDEX 50 MG ONCE PER DAY (View Casedex 50 Mg Once Per Day Review and Casedex 50 Mg Once Per Day Label ).

4604291-3 |
on Dec 01, 2004 Male patient from , 78 years of age, weighting 160.0 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Vantas (View Usage). . Vantas dosage: 50 Mg, Once Per Year, Implant 057. During the same period patient was treated with GLUCOTROL (View Glucotrol Review and Glucotrol Label ), GLUCOPHAGE 500 MG TID (View Glucophage 500 Mg Tid Review and Glucophage 500 Mg Tid Label ), CASEDEX 50 MG ONCE PER DAY (View Casedex 50 Mg Once Per Day Review and Casedex 50 Mg Once Per Day Label ).

4589719-X | Chest Pain, Delirium, Implant Site Pain, Pain In Extremity, Posture Abnormal
Patient was taking Vantas (View Usage). After Vantas was administered, patient had the following side effects: chest pain (What is chest pain?), delirium, implant site pain, pain in extremity, posture abnormal on Feb 14, 2005 from Additional patient health information: Male patient , 84 years of age, weighting 150.0 lb, was diagnosed with prostate cancer (What is prostate cancer?) and. Vantas dosage: 50 Mg, 1/year, 0.57implant. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ZANTAC (View Zantac Review and Zantac Label ), CLINDEX (View Clindex Review and Clindex Label ), MEGACE (View Megace Review and Megace Label ), LIBRAX (View Librax Review and Librax Label ), PERPHENOZINE (View Perphenozine Review and Perphenozine Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), CELEXA (View Celexa Review and Celexa Label ). Patient was hospitalized.